Fluconazole Dosing for Candida Infections
For treating candida infections, fluconazole should be administered with a loading dose of 800 mg (12 mg/kg), followed by 400 mg (6 mg/kg) daily for most invasive infections, with specific adjustments based on infection site and severity. 1
Dosing Recommendations by Infection Type
Invasive Candidiasis/Candidemia
- Initial therapy: Loading dose of 800 mg (12 mg/kg), then 400 mg (6 mg/kg) daily 1
- Duration: At least 2 weeks after documented clearance of Candida from bloodstream 1
- Alternative: For moderately severe to severe illness or recent azole exposure, consider an echinocandin instead 1
Oropharyngeal Candidiasis
- Mild disease: 100-200 mg daily for 7-14 days 1
- Moderate to severe disease: 200 mg on first day, then 100 mg daily for 7-14 days 2
Esophageal Candidiasis
- Standard regimen: 200 mg on first day, followed by 100 mg daily 2
- Severe cases: Doses up to 400 mg daily may be used 2
- Duration: Minimum 3 weeks and at least 2 weeks following symptom resolution 2
Vaginal Candidiasis
- Uncomplicated: Single 150 mg dose 1
- Recurrent: 10-14 days induction with topical or oral azole, followed by 150 mg weekly for 6 months 1
Urinary Tract Candidiasis
- Standard regimen: 200 mg (3 mg/kg) daily for 2 weeks for fluconazole-susceptible organisms 1
- Urologic procedures: 400 mg (6 mg/kg) daily for several days before and after the procedure 1
Special Considerations
Candida Species Considerations
- C. albicans: Generally susceptible to standard fluconazole doses 1
- C. glabrata: Higher doses (800 mg daily) often recommended, but efficacy is lower (50%) 1, 3
- C. krusei: Intrinsically resistant to fluconazole; alternative antifungals should be used 3
- C. parapsilosis: Highly responsive to fluconazole (93% efficacy) 3
Patient-Specific Adjustments
Renal Impairment
- Creatinine clearance >50 mL/min: 100% of recommended dose
- Creatinine clearance ≤50 mL/min (no dialysis): 50% of recommended dose
- Hemodialysis: 100% of recommended dose after each hemodialysis 2
Pediatric Dosing
- Oropharyngeal candidiasis: 6 mg/kg on first day, then 3 mg/kg daily
- Esophageal candidiasis: 6 mg/kg on first day, then 3 mg/kg daily (up to 12 mg/kg/day)
- Systemic infections: 6-12 mg/kg/day 2
Treatment Duration
- Candidemia: Minimum 2 weeks after blood culture clearance 1
- Esophageal candidiasis: Minimum 3 weeks and at least 2 weeks after symptom resolution 2
- Oropharyngeal candidiasis: Minimum 7-14 days 4
Common Pitfalls and Caveats
- Fluconazole has poor activity against C. glabrata and no activity against C. krusei; identify species before committing to fluconazole therapy 1, 3
- Fluconazole has significant drug interactions through cytochrome P450 inhibition; review patient's medication list before prescribing 1
- For patients with recent azole exposure or critical illness, an echinocandin is preferred for initial therapy 1
- Inadequate dosing is a common cause of treatment failure; use appropriate loading doses for invasive infections 1
- CSF and vitreous penetration of fluconazole is excellent (>70% of serum concentration), making it suitable for CNS and ocular candidiasis 1
Fluconazole's excellent bioavailability (90%) means oral and intravenous doses are essentially equivalent, allowing for easy transition between routes of administration 1.